Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for vaccines in Uganda has been increasing steadily over the years. This can be attributed to the rise in awareness about the importance of vaccination and the government's efforts to provide free vaccinations to its citizens. In this writeup, we will explore the trends and developments in the Other Vaccines market in Uganda.
Customer preferences: Uganda has a population of over 42 million people, with a majority living in rural areas. The country has a high birth rate, and the demand for vaccines is expected to increase with the growing population. The most common vaccines administered in Uganda are those for measles, polio, and yellow fever. However, there has been a growing demand for other vaccines such as pneumococcal, rotavirus, and HPV vaccines.
Trends in the market: The Other Vaccines market in Uganda has been growing steadily in recent years. The market is being driven by an increase in demand for vaccines, especially among children. The government's efforts to provide free vaccinations to its citizens have also contributed to the growth of the market. The private sector is also playing a significant role in the market, with many private clinics and hospitals offering vaccines at affordable prices.
Local special circumstances: Uganda faces several challenges in the vaccination sector. One of the main challenges is the lack of access to vaccines in rural areas. The government is working to address this issue by increasing the number of health facilities in rural areas and providing mobile vaccination clinics. Another challenge is the low awareness about the importance of vaccination among some communities. The government and other stakeholders are working to educate these communities about the benefits of vaccination.
Underlying macroeconomic factors: Uganda's economy has been growing steadily over the years, with a GDP growth rate of 6.5% in 2019. This has led to an increase in disposable income, which has contributed to the growth of the Other Vaccines market. The government's efforts to provide free vaccinations have also played a significant role in the growth of the market. However, the country still faces several challenges such as inadequate funding and a shortage of healthcare workers. The government and other stakeholders are working to address these issues to ensure that the vaccination sector continues to grow.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
